Prasugrel Reduces Agonists′ Inducible Platelet Activation and Leukocyte-Platelet Interaction more efficiently than Clopidogrel

Platelet Function During Extended Prasugrel and Clopidogrel Therapy for Patients With ACS Treated Without Revascularization

(2012) Paul A. Gurbel   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Vorapaxar in the Secondary Prevention of Atherothrombotic Events

(2012) David A. Morrow et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Thr715Pro variant impairs terminal glycosylation of P-selectin

(2012) H. Subramanian et al.   THROMBOSIS AND HAEMOSTASIS

High On-Treatment Platelet Reactivity After Prasugrel Loading Dose and Cardiovascular Events After Percutaneous Coronary Intervention in Acute Coronary Syndromes

(2011) Laurent Bonello et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes

(2011) Pierluigi Tricoci et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical, genetic and confounding factors determine the dynamics of the in vitro response/non response to clopidogrel

(2011) Thomas Gremmel et al.   THROMBOSIS AND HAEMOSTASIS

Influence of cytochrome 2C19 allelic variants on on-treatment platelet reactivity evaluated by five different platelet function tests

(2011) Thomas Gremmel et al.   THROMBOSIS RESEARCH

Impact of Chronic Kidney Disease on Platelet Function Profiles in Diabetes Mellitus Patients With Coronary Artery Disease Taking Dual Antiplatelet Therapy

(2010) Dominick J. Angiolillo et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Consensus and Future Directions on the Definition of High On-Treatment Platelet Reactivity to Adenosine Diphosphate

(2010) Laurent Bonello et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Is TRAP-6 suitable as a positive control for platelet reactivity when assessing response to clopidogrel?

(2010) Thomas Gremmel et al.   PLATELETS

Relation of Body Mass Index to High On-Treatment Platelet Reactivity and of Failed Clopidogrel Dose Adjustment According to Platelet Reactivity Monitoring in Patients Undergoing Percutaneous Coronary Intervention

(2009) Nathalie Bonello-Palot et al.   AMERICAN JOURNAL OF CARDIOLOGY

The formation of monocyte–platelet aggregates is independent of on-treatment residual agonists’-inducible platelet reactivity

(2009) Thomas Gremmel et al.   ATHEROSCLEROSIS

Regulation of PAR-1 in patients undergoing percutaneous coronary intervention: effects of unfractionated heparin and bivalirudin

(2009) R. B. Eslam et al.   EUROPEAN HEART JOURNAL

Calcium-channel blockers decrease clopidogrel-mediated platelet inhibition

(2009) T. Gremmel et al.   HEART

New P2Y12blockers

(2009) M. CATTANEO   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Adenosine diphosphate-inducible platelet reactivity shows a pronounced age dependency in the initial phase of antiplatelet therapy with clopidogrel

(2009) T. GREMMEL et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Tissue Factor in Patients With Acute Coronary Syndromes

(2008) Marta Brambilla et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Patients With Poor Responsiveness to Thienopyridine Treatment or With Diabetes Have Lower Levels of Circulating Active Metabolite, but Their Platelets Respond Normally to Active Metabolite Added Ex Vivo

(2008) David Erlinge et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY